Naoya Hashimoto

Prognostic value of medulloblastoma extent of resection after accounting for molecular subgroup: a retrospective integrated clinical and molecular analysis

Eric M. Thompson, Thomas Hielscher, Éric Bouffet et al. · The Lancet Oncology · 2016 · 369 citations · Full text

Medicine, Oncology, Surgery +17

A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas

Hideyuki Arita, Kai Yamasaki, Yuko Matsushita et al. · Acta Neuropathologica Communications · 2016 · 265 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Fiber-tracking does not accurately estimate size of fiber bundle in pathological condition: initial neurosurgical experience using neuronavigation and subcortical white matter stimulation

Manabu Kinoshita, Kei Yamada, Naoya Hashimoto et al. · NeuroImage · 2005 · 264 citations

Medicine, Neurological Surgery, Neurosurgery +12

Phase II clinical trial of Wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme

Shuichi Izumoto, Akihiro Tsuboi, Tsuyoshi Suzuki et al. · Journal of neurosurgery · 2008 · 213 citations

Medicine, Immunology, Oncology +17

Effects of Surgery With Salvage Stereotactic Radiosurgery Versus Surgery With Whole-Brain Radiation Therapy in Patients With One to Four Brain Metastases (JCOG0504): A Phase III, Noninferiority, Randomized Controlled Trial

Takamasa Kayama, Shinya Sato, Kaori Sakurada et al. · Journal of Clinical Oncology · 2018 · 183 citations · Full text

Medicine, Oncology, Surgery +15